Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer, to South Korea

Business Wire Friday, 13 January 2017 ()
Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer, to South KoreaSAN DIEGO--(BUSINESS WIRE)--Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced its randomized, controlled Phase 2/3 clinical trial, called Toca 5, is now enrolling patients in South Korea. The trial is ongoing in the United States, Canada and Israel. The study compares a cancer-selective virus, Toca 511 (vocimagene amiretrorepvec), in combination with Toca FC (extended-release 5-fluorocytosine), to standard of care in patients with first or second recurrence
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

Living Cell Technologies’ patent application published in the U.S.

The choroid plexus is a plexus of cells that produces the cerebrospinal fluid in the ventricles of the brain. The published application recognises a significant...
Proactive Investors - Business

Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium

Chi-Med Presents Phase I/II Clinical Data for Selective VEGFR Inhibitor Fruquintinib at the 2017 Gastrointestinal Cancers Symposium
LONDON--(BUSINESS WIRE)--Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that data from the ongoing Phase I/II clinical trial...
Business Wire - Press Releases

U. Colorado Cancer Center Trial Shows Tucatinib Progressing in Pivotal Trial Against HER2+ Breast Cancer

Twenty-seven percent of 50 heavily pretreated patients with stage IV HER2+ breast cancer saw clinical benefit from the drug, with at least “stable disease”...
PRWeb - Press Releases

ORYZON Announces First Patient Dosed in Phase 1 Trial of the LSD1 inhibitor RG6016 in Small Cell Lung Cancer (SCLC)

Second clinical trial with RG6016, while the first one in Acute Leukemia is almost completed
Marketwired - Press Releases

AB Science announces publication in The Lancet of phase 3 clinical trial results demonstrating masitinib is effective and well tolerated in the treatment of adult patients with mastocytosis

Paris, 9 January 2017, 8am *AB Science announces publication in The Lancet of phase 3 clinical trial results demonstrating masitinib is effective and well...
GlobeNewswire - Press Releases

Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial

Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies Announces Launch of Sixth Site MedStar National Rehabilitation Hospital in Washington D.C. for Pivotal...
Business Wire - Press Releases

MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes

MUNICH & PLANEGG, Germany--(BUSINESS WIRE)--MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its partner Novartis will...
Business Wire - Press Releases

US FDA agrees to accelerated review of Merck immunotherapy drug combination treatment for lung cancer

Drugs giant Merck & Co. Inc. (NYSE:MRK) has gained a march on its rivals after US regulators agreed to an accelerated review of the use of one of its...
Proactive Investors - Business


You Might Like


Other recent news in Press Releases

US Offshore Deepwater Gulf of Mexico South Santa Cruz Project PANORAMA Oil and Gas Upstream Analysis Report 2016 - Research and MarketsEaton’s New Circuit Design SOFTWARE Studio Allows Customers to Create Custom Manifold Designs Quickly and Easily
On Dr. MARTIN LUTHER KING JR. Day Nike Announces New Partnerships to Promote Equality in Communities across the U.S.Governor Martinez Proclaims Jan. 22-28 “New MEXICO School Choice Week”; Joins Leaders Nationwide in Celebrating Opportunity in Education
SEA-US Trans-Pacific Cable System Selects CoreSite’s LOS ANGELES Data Center Campus for Its North American Access PointBOB BECKEL to Return as Co-Host on FOX News Channel’s The Five
KURT ANGLE to Be Inducted into WWE® Hall of FameGERMAN Retailer Bartels-Langness Selects Verifone to Offer Customers Intuitive, Multimedia Self-Checkout Experiences
U.S. Mayors Hold PRESS CONFERENCE to Discuss Bipartisan Immigration EffortsFlow Partners with MANCHESTER UNITED To Bring the 'FA Cup Trophy' To The Caribbean

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+